To test whether c-Jun plays a central role in the development of CIPN, we applied the small molecule inhibitor of the Jun N-terminal kinase, SP600125, to iPSC-DSN treated with neurotoxic chemotherapy. This evidence concerns the gene MAPK8 and Charcot-Marie-Tooth disease type 3.